Issue 4/2019
Content (32 Articles)
Chimeric antigen receptor T cell targeting B cell maturation antigen immunotherapy is promising for multiple myeloma
Tiantian Ma, Jing Shi, Huasheng Liu
High-dose etoposide could discriminate the benefit from autologous peripheral blood stem cell transplantation in the patients with refractory diffuse large B cell lymphoma
Yu Cai, Liping Wan, Juan Yang, Jun Zhu, Jieling Jiang, Su Li, Xianmin Song, Chun Wang
Common fetal hemoglobin variants in Lebanese patients bearing the codon 29 beta gene mutation associated with different thalassemia phenotypes
Valentina Brancaleoni, Hassan M. Moukhadder, Dario Consonni, Suzanne Koussa, Elena Di Pierro, Maria Domenica Cappellini, Ali Taher
Inhaled steroids associated with decreased macrophage markers in nonasthmatic individuals with sickle cell disease in a randomized trial
Arielle L. Langer, Andrew Leader, Seunghee Kim-Schulze, Yelena Ginzburg, Miriam Merad, Jeffrey Glassberg
The burden of psychiatric illnesses in adult patients with beta-thalassemia: a 5-year nationwide inpatient evaluation in the United States
Krupa Patel, Siddhi Bhivandkar, Rupak Desai, Todd Antin
Role of platelets in thrombin generation amongst patients with non-transfusion-dependent thalassaemia
Chuen Wen Tan, Wan Hui Wong, Roserahayu Idros, Yiong Huak Chan, Hartirathpal Kaur, Alvin Ren Kwang Tng, Lai Heng Lee, Heng Joo Ng, Ai Leen Ang
Next-generation sequencing with a 54-gene panel identified unique mutational profile and prognostic markers in Chinese patients with myelofibrosis
Harinder Gill, Ho-Wan Ip, Rita Yim, Wing-Fai Tang, Herbert H. Pang, Paul Lee, Garret M. K. Leung, Jamilla Li, Karen Tang, Jason C. C. So, Rock Y. Y. Leung, Jun Li, Gianni Panagioutou, Clarence C. K. Lam, Yok-Lam Kwong
Treatment patterns and comparative analysis of non-intensive regimens in elderly acute myeloid leukemia patients—a real-world experience from India
Govind B. Kanakasetty, Chethan R, Lakshmaiah K C, Lokanatha Dasappa, Linu Abraham Jacob, Suresh Babu M C, Lokesh K N, Rudresha Antapura Haleshappa, Rajeev L K, Smitha Carol Saldanha, Koppaka Deepak, Patidar Rajesh, Vikas Asati
Impact of comorbidities and body mass index in patients with myelofibrosis treated with ruxolitinib
Massimo Breccia, Daniela Bartoletti, Massimiliano Bonifacio, Giuseppe A. Palumbo, Nicola Polverelli, Elisabetta Abruzzese, Micaela Bergamaschi, Alessia Tieghi, Mario Tiribelli, Alessandra Iurlo, Francesco Cavazzini, Nicola Sgherza, Gianni Binotto, Alessandro Isidori, Mariella D’Adda, Monica Crugnola, Costanza Bosi, Florian Heidel, Matteo Molica, Luigi Scaffidi, Daniele Cattaneo, Roberto Latagliata, Giuseppe Auteri, Roberto M. Lemoli, Renato Fanin, Domenico Russo, Franco Aversa, Antonio Cuneo, Gianpietro Semenzato, Lucia Catani, Michele Cavo, Nicola Vianelli, Robin Foà, Francesca Palandri
Six versus eight doses of rituximab in patients with aggressive B cell lymphoma receiving six cycles of CHOP: results from the “Positron Emission Tomography-Guided Therapy of Aggressive Non-Hodgkin Lymphomas” (PETAL) trial
Andreas Hüttmann, Jan Rekowski, Stefan P. Müller, Bernd Hertenstein, Christiane Franzius, Rolf Mesters, Matthias Weckesser, Frank Kroschinsky, Jörg Kotzerke, Arnold Ganser, Frank M. Bengel, Paul La Rosée, Martin Freesmeyer, Heinz-Gert Höffkes, Andreas Hertel, Dirk Behringer, Gabriele Prange-Krex, Martin Griesshammer, Jens Holzinger, Stefan Wilop, Thomas Krohn, Aruna Raghavachar, Georg Maschmeyer, Ingo Brink, Roland Schroers, Tobias Gaska, Helga Bernhard, Aristoteles Giagounidis, Jochen Schütte, Ariane Dienst, Hubertus Hautzel, Ralph Naumann, Alfred Klein, Dennis Hahn, Gabriele Pöpperl, Matthias Grube, Jörg Marienhagen, Andreas Schwarzer, Lars Kurch, Thomas Höhler, Heike Steiniger, Holger Nückel, Thomas Südhoff, Wolfgang Römer, Marcus Brinkmann, Claudia Ose, Ferras Alashkar, Christine Schmitz, Jan Dürig, Dieter Hoelzer, Karl-Heinz Jöckel, Wolfram Klapper, Ulrich Dührsen
Early detection value of 18F-FDG-PET/CT for drug-induced lung injury in lymphoma
Meixin Zhao, Weifang Zhang
(R)-GEMOX chemotherapy for unfit patients with refractory or recurrent primary central nervous system lymphoma: a LOC study
A. Collignon, C. Houillier, G. Ahle, O. Chinot, S. Choquet, A. Schmitt, P. Agape, C. Soussain, K. Hoang-Xuan, Emeline Tabouret
The role of ABCB1 polymorphism as a prognostic marker for primary central nervous system lymphoma
Ting Wu, Hui Kang, Dongxiao Zhuang, Yan Ma, Zhiguang Lin, Dina Suolitiken, Bobin Chen, Xiaoping Xu
Oncology nurse phone calls halve the risk of reduced dose intensity of immunochemotherapy: results of the randomized FORTIS study in chronic lymphocytic leukemia.
Loic Ysebaert, Marie Larcher, Gisele Compaci, Lucie Oberic, Laurence Sahnes, Anne Banos, Carla Araujo, Agnes Sommet, Guy Laurent, Fabien Despas
Survival differences in multiple myeloma in Latin America and Asia: a comparison involving 3664 patients from regional registries
Vania T. M. Hungria, Jae Hoon Lee, Angelo Maiolino, Edvan de Queiroz Crusoe, Gracia Martinez, Rosane Bittencourt, Gislaine Oliveira Duarte, Dorotea Beatriz Fantl, Juan Ramon Navarro, Guillermo Conte, David Gomez-Almaguer, Guillermo J. Ruiz-Argüelles, Kihyun Kim, Kazuyuki Shimizu, Wenming Chen, Shang-YI Huang, Wee-Joo Chng, Chor Sang Chim, Weerasak Nawarawong, Brian Durie
Simplified novel prognostic score for real-life older adults with multiple myeloma—registry-based analysis
J. Radocha, R. Hájek, L. Brožová, L. Pour, I. Špička, J. Minařík, E. Gregora, A. Jungová, T. Jelínek, A. Heindorfer, M. Sýkora, V. Maisnar
Clinical characteristics and prognosis of immunoglobulin D myeloma in the novel agent era
Lei Chen, Fengjuan Fan, Jun Deng, Jian Xu, Aoshuang Xu, Chunyan Sun, Yu Hu
Cyclosporine levels > 195 μg/L on day 10 post-transplant was associated with significantly reduced acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation
Monica Bianchi, Dominik Heim, Claudia Lengerke, Jörg Halter, Sabine Gerull, Martina Kleber, Dimitrios A. Tsakiris, Jakob Passweg, Alexandar Tzankov, Michael Medinger
Vascular density and inflammatory infiltrate in primary oral squamous cell carcinoma and after allogeneic hematopoietic stem cell transplantation
Roberto Tamma, Luisa Limongelli, Eugenio Maiorano, Domenico Pastore, Eliano Cascardi, Angela Tempesta, Paola Carluccio, Mauro G. Mastropasqua, Saverio Capodiferro, Claudia Covelli, Monica Pentenero, Tiziana Annese, Gianfranco Favia, Giorgina Specchia, Domenico Ribatti
Incidence, risk factors, and clinical significance of Epstein–Barr virus reactivation in myelodysplastic syndrome after allogeneic haematopoietic stem cell transplantation
Hong Wang, Tong-Tong Zhang, Jia-Qian Qi, Tian-Tian Chu, Miao Miao, Hui-Ying Qiu, Cheng-Cheng Fu, Xiao-Wen Tang, Chang-Geng Ruan, De-Pei Wu, Yue Han
Allogeneic hematopoietic stem cells transplantation improves the survival of intermediate-risk acute myeloid leukemia patients aged less than 60 years
Ying Zhang, Yimin Zhang, Qi Chen, Gusheng Tang, Weiping Zhang, Jianmin Yang, Jianmin Wang, Xiaoxia Hu
Cytomegalovirus infection is associated with AML relapse after allo-HSCT: a meta-analysis of observational studies
Yu-Lin Zhang, Yan Zhu, Qing Xiao, Li Wang, Lin Liu, Xiao-Hua Luo
An under-recognized cause of copper deficiency mimicking myelodysplastic syndrome
Margaret A. Stafford, Ming Y. Lim
Deciphering the prognostic significance of autoimmune disorders in myelodysplastic syndromes
Claudio Fozza
Therapeutic strategies for durable response in plasma cell granulomas in the central nervous system
Ameet Patel, Mehmet H. Kocoglu, Akash Kaul
High efficacy of eculizumab treatment for fulminant hemolytic anemia in primary cold agglutinin disease
Kenichi Makishima, Naoshi Obara, Kantaro Ishitsuka, Shinichiro Sukegawa, Sakurako Suma, Yusuke Kiyoki, Naoko Baba, Tatsuhiro Sakamoto, Takayasu Kato, Manabu Kusakabe, Hidekazu Nishikii, Naoki Kurita, Yasuhisa Yokoyama, Mamiko Sakata-Yanagimoto, Yuichi Hasegawa, Shigeru Chiba
Primary antifungal prophylaxis with micafungin after allogeneic hematopoietic stem cell transplantation: a monocentric prospective study
Aliénor Xhaard, Raphael Porcher, Anne Bergeron, Alexandre Alanio, Sophie Touratier, Stéphane Bretagne, Constance de Margerie-Mellon, Flore Sicre de Fontbrune, Raphael Itzykson, Tereza Coman, Marie Robin, Aurélie Cabannes-Hamy, Gérard Socié, Régis Peffault de Latour
Low-dose splenic irradiation is an alternative therapy for symptomatic splenomegaly in patients with myelofibrosis
Ming-Shan Huang, Yu-Hsuan Chen, Chun-Wei Wang, Ming Yao, Sung-Hsin Kuo
A case report of congenital erythropoietic anemia II in China with a novel mutation
Hong Zhang, Wuqing Wan, Xiaoyan Liu, Chuan Wen, Ying Liu, Senlin Luo, Xiao Sun, Shizhe Liu
Anti-glomerular basement membrane disease due to monoclonal IgG Lambda antibodies: a very rare case of monoclonal gammopathy of renal significance
C. Peña, R. Valjalo, X. Rocca, M. Roa, A. Morales, G. P. Méndez
Long-term response to daratumumab in a patient with advanced immunoglobulin light-chain (AL) amyloidosis with organ damage
Martina Canichella, Alessandra Serrao, Giorgia Annechini, Gianna Maria D’Elia, Maria Lucia De Luca, Alessandro Pulsoni
Secondary diffuse large B cell lymphoma of the central nervous system: retrospective review of case series
Hammad Tashkandi, Mark L. Cohen, Marta E. Couce